In this study, MIR210HG was identified as a protective factor, and it has been reported to promote tumour progression in endometrial cancer, non-small cell lung cancer, triple-negative breast cancer, cervical cancer, colorectal cancer, and hepatocellular carcinoma 34-41. Here, MIR210HG is linked to non-small cell lung carcinoma.